123 related articles for article (PubMed ID: 11739695)
21. Activity of Friend mink cell focus-forming retrovirus during myelo-erythroid hematopoiesis.
Baum C; Eckert HG; Stocking C; Ostertag W
Exp Hematol; 1996 Feb; 24(2):364-70. PubMed ID: 8641367
[TBL] [Abstract][Full Text] [Related]
22. Protein-DNA interactions in vivo of an erythroid-specific, human beta-globin locus enhancer.
Reddy PM; Shen CK
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8676-80. PubMed ID: 1924329
[TBL] [Abstract][Full Text] [Related]
23. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody.
Seth A; Robinson L; Thompson DM; Watson DK; Papas TS
Oncogene; 1993 Jul; 8(7):1783-90. PubMed ID: 8510925
[TBL] [Abstract][Full Text] [Related]
24. Erythroid regulatory elements.
Raich N; Romeo PH
Stem Cells; 1993 Mar; 11(2):95-104. PubMed ID: 8096156
[TBL] [Abstract][Full Text] [Related]
25. Verification of the in vivo activity of three distinct cis-acting elements within the Gata1 gene promoter-proximal enhancer in mice.
Shimizu R; Hasegawa A; Ottolenghi S; Ronchi A; Yamamoto M
Genes Cells; 2013 Nov; 18(11):1032-41. PubMed ID: 24118212
[TBL] [Abstract][Full Text] [Related]
26. Roles of hematopoietic transcription factors GATA-1 and GATA-2 in the development of red blood cell lineage.
Ohneda K; Yamamoto M
Acta Haematol; 2002; 108(4):237-45. PubMed ID: 12432220
[TBL] [Abstract][Full Text] [Related]
27. One enhancer mediates mafK transcriptional activation in both hematopoietic and cardiac muscle cells.
Katsuoka F; Motohashi H; Onodera K; Suwabe N; Engel JD; Yamamoto M
EMBO J; 2000 Jun; 19(12):2980-91. PubMed ID: 10856242
[TBL] [Abstract][Full Text] [Related]
28. In Vivo Deletion of the Cebpa +37 kb Enhancer Markedly Reduces Cebpa mRNA in Myeloid Progenitors but Not in Non-Hematopoietic Tissues to Impair Granulopoiesis.
Guo H; Cooper S; Friedman AD
PLoS One; 2016; 11(3):e0150809. PubMed ID: 26937964
[TBL] [Abstract][Full Text] [Related]
29. SF-1 (steroidogenic factor-1), C/EBPbeta (CCAAT/enhancer binding protein), and ubiquitous transcription factors NF1 (nuclear factor 1) and Sp1 (selective promoter factor 1) are required for regulation of the mouse aldose reductase-like gene (AKR1B7) expression in adrenocortical cells.
Aigueperse C; Val P; Pacot C; Darne C; Lalli E; Sassone-Corsi P; Veyssiere G; Jean C; Martinez A
Mol Endocrinol; 2001 Jan; 15(1):93-111. PubMed ID: 11145742
[TBL] [Abstract][Full Text] [Related]
30. Mutation of all Runx (AML1/core) sites in the enhancer of T-lymphomagenic SL3-3 murine leukemia virus unmasks a significant potential for myeloid leukemia induction and favors enhancer evolution toward induction of other disease patterns.
Sørensen KD; Quintanilla-Martinez L; Kunder S; Schmidt J; Pedersen FS
J Virol; 2004 Dec; 78(23):13216-31. PubMed ID: 15542674
[TBL] [Abstract][Full Text] [Related]
31. Specificity of transcriptional regulation by the zinc finger transcription factors Sp1, Sp3, and Egr-1.
Al-Sarraj A; Day RM; Thiel G
J Cell Biochem; 2005 Jan; 94(1):153-67. PubMed ID: 15523672
[TBL] [Abstract][Full Text] [Related]
32. Suppressor mutations within the core binding factor (CBF/AML1) binding site of a T-cell lymphomagenic retrovirus.
Martiney MJ; Levy LS; Lenz J
J Virol; 1999 Mar; 73(3):2143-52. PubMed ID: 9971797
[TBL] [Abstract][Full Text] [Related]
33. Production of human glucocerebrosidase in mice after retroviral gene transfer into multipotential hematopoietic progenitor cells.
Correll PH; Fink JK; Brady RO; Perry LK; Karlsson S
Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8912-6. PubMed ID: 2573069
[TBL] [Abstract][Full Text] [Related]
34. Multiple elements in human beta-globin locus control region 5' HS 2 are involved in enhancer activity and position-independent, transgene expression.
Caterina JJ; Ciavatta DJ; Donze D; Behringer RR; Townes TM
Nucleic Acids Res; 1994 Mar; 22(6):1006-11. PubMed ID: 8152905
[TBL] [Abstract][Full Text] [Related]
35. Enhanced transgene expression in primitive hematopoietic progenitor cells and embryonic stem cells efficiently transduced by optimized retroviral hybrid vectors.
Ketteler R; Glaser S; Sandra O; Martens UM; Klingmüller U
Gene Ther; 2002 Apr; 9(8):477-87. PubMed ID: 11948372
[TBL] [Abstract][Full Text] [Related]
36. An erythroid specific enhancer upstream to the gene encoding the cell-type specific transcription factor GATA-1.
Nicolis S; Bertini C; Ronchi A; Crotta S; Lanfranco L; Moroni E; Giglioni B; Ottolenghi S
Nucleic Acids Res; 1991 Oct; 19(19):5285-91. PubMed ID: 1656391
[TBL] [Abstract][Full Text] [Related]
37. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1.
Pevny L; Simon MC; Robertson E; Klein WH; Tsai SF; D'Agati V; Orkin SH; Costantini F
Nature; 1991 Jan; 349(6306):257-60. PubMed ID: 1987478
[TBL] [Abstract][Full Text] [Related]
38. Multiple factors interacting at the GATA sites of the gonadotropin-releasing hormone neuron-specific enhancer regulate gene expression.
Lawson MA; Buhain AR; Jovenal JC; Mellon PL
Mol Endocrinol; 1998 Mar; 12(3):364-77. PubMed ID: 9514154
[TBL] [Abstract][Full Text] [Related]
39. Manipulation of mouse hematopoietic progenitors by specific retroviral infection.
Murphy GJ; Göttgens B; Vegiopoulos A; Sanchez MJ; Leavitt AD; Watson SP; Green AR; Frampton J
J Biol Chem; 2003 Oct; 278(44):43556-63. PubMed ID: 12928443
[TBL] [Abstract][Full Text] [Related]
40. Single-nucleotide human disease mutation inactivates a blood-regenerative GATA2 enhancer.
Soukup AA; Zheng Y; Mehta C; Wu J; Liu P; Cao M; Hofmann I; Zhou Y; Zhang J; Johnson KD; Choi K; Keles S; Bresnick EH
J Clin Invest; 2019 Mar; 129(3):1180-1192. PubMed ID: 30620726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
